BioProtection Systems Corporation (BPSC) was an American biotechnology company based in Ames, Iowa.[1]
History
BPSC was founded in 2005 as a subsidiary of NewLink Genetics.[1:1]
Ebola
On August 5, 2014, BPSC announced that it had received an initial $1 million contract from the Defense Threat Reduction Agency (DTRA) to bring the rVSV-ZEBOV-G vaccine candidate against Ebola to clinical trials. The candidate was licensed from the Public Health Agency of Canada (PHAC).[2] Dr. Robert Malone was tapped by the DTRA to lead the program.[3][4]
External links
Home. BioProtection Systems. Retrieved April 10, 2010, from https://web.archive.org/web/20100410020449/http://www.bpsys.net/ ↩︎ ↩︎
Link, G. (2014, August 5). NewLink Genetics Corporation, Through Its Wholly Owned Subsidiary, BioProtection Systems Corporation, Secures a Letter Contract From the Defense Threat Reduction Agency for Testing and Evaluation of Ebola Virus Vaccine. Lumos Pharma. http://archive.today/2023.02.25-194304/http://investors.linkp.com/news-releases/news-release-details/newlink-genetics-corporation-through-its-wholly-owned-subsidiary ↩︎
The Team. Atheric Pharmaceutical. Retrieved July 14, 2017, from https://web.archive.org/web/20170714055404/http://www.atheric.com/team ↩︎
Malone, R. W. (2017, March). RWM CV. Squarespace. https://web.archive.org/web/20230119104151/https://static1.squarespace.com/static/550b0ac4e4b0c16cdea1b084/t/58e5406b5016e1f1acacae75/1491419246742/RWM+CV+March+2017.pdf ↩︎
